BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML by Ossenkoppele, G, Vyas, P

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party by Schuurhuis, G, Heuser, M, Freeman, S, Béné, M, Buccisano, F, Cloos, J, Grimwade, D, Haferlach, T, Hills, R, Hourigan, C, Jorgensen, J, Kern, W, Lacombe, F, Maurillo, L, Preudhomme, C, Van Der Reijden, B, Thiede, C, Venditti, A, Vyas, P, Wood, B, Walter, R, Döhner, K, Roboz, G, Ossenkoppele, G

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. by van de Loosdrecht, A, Alhan, C, Béné, M, Della Porta, MG, Dräger, A, Feuillard, J, Font, P, Germing, U, Haase, D, Homburg, C, Ireland, R, Jansen, J, Kern, W, Malcovati, L, Te Marvelde, J, Mufti, G, Ogata, K, Orfao, A, Ossenkoppele, G, Porwit, A, Preijers, F, Richards, S, Schuurhuis, G, Subirá, D, Valent, P

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia by Craddock, C, Versluis, J, Labopin, M, Socie, G, Huynh, A, Deconinck, E, Volin, L, Milpied, N, Bourhis, JH, Rambaldi, A, Chevallier, P, Blaise, D, Manz, M, Vellenga, E, Vekemans, MC, Maertens, J, Passweg, J, Vyas, P, Schmid, C, Löwenberg, B, Ossenkoppele, G, Mohty, M, Cornelissen, JJ, Nagler, A, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and HOVON‐SAKK